Back to Annual Meeting
Back to Annual Meeting
|
Back to Annual Meeting
|
|
Back to Annual Meeting
|
APHA Scientific Session and Event Listing |
3385.0: Monday, November 06, 2006: 4:30 PM-6:00 PM | |||
Oral | |||
| |||
| Learning Objectives: See individual abstracts | |||
| Elizabeth L. Merrick, PhD | |||
| Factors affecting physician willingness to prescribe buprenorphine: Differences between experienced prescribers, new prescribers, and non-prescribers Julie Netherland, MSW, Michael Botsko, MSW, James Egan, MPH, Linda Weiss, PhD, Chinazo Cunningham, MD, Ruth Finkelstein, ScD, Hillary Kunins, MD, MPH, Andrew Saxon, MD, Nancy Sohler, PhD, MPH, Lynn Sullivan, MD, David Fiellin, MD | |||
Treatment outcomes for persons with co-occurring substance abuse and mental health disorders: Comparison of methadone programs using integrated and parallel approaches ![[ Recorded presentation ]](/static/img/filetypes/16x16/wrf.gif){kind=small} Katherine R. Disare, BA, John A. Hornik, PhD | |||
| Attributes of substance abuse organizations adopting buprenorphine for the office-based treatment of opiate dependence Sarita Bhalotra, MD, PhD, Timothy C. Martin, PhD, Mathew Neuman, MS, Stanley S. Wallack, PhD, Jon Chilingerian, PhD | |||
| Substance-use screening in primary care: Requirements and monitoring by health plans Alex Hoyt, RN, MSN, Constance M. Horgan, ScD, Deborah W. Garnick, ScD, Elizabeth L. Merrick, PhD | |||
| Physician interventions for patient substance use disorders: What do we know? What needs to be done? Richard A. Yoast, PhD | |||
| See individual abstracts for presenting author's disclosure statement and author's information. | |||
| Organized by: | Alcohol, Tobacco, and Other Drugs | ||
| CE Credits: | CME, Health Education (CHES), Nursing | ||
The 134th Annual Meeting & Exposition (November 4-8, 2006) of APHA